Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ASND:
- Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
- New Post Hoc Analysis Showed Substantial Improvement in Observed Estimated Glomerular Filtration Rate (eGFR), in TransCon PTH-Treated Adults with Hypoparathyroidism
- Ascendis Pharma Reports Second Quarter 2023 Financial Results
- Options Volatility and Implied Earnings Moves Today, September 05, 2023
- Options Volatility and Implied Earnings Moves This Week, September 05 – September 08, 2023